The University of Chicago /ID# 155364

5801 South Ellis Avenue
Chicago, Illinois 60637

We've found

1 trials

at this facility

A Study Evaluating Venetoclax Alone and in Combination With Azacitidine in Subjects With Relapsed/Refractory Myelodysplastic Syndromes (MDS)

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Chicago, IL

Use our guide to learn which trials are right for you!